foxo4-dri senolytic 2023 2024 study Targeting the FOXO4-p53 axis by retro-inverso peptide agents: a pharmacological strategy to mitigate brain aging and cognitive decline | Naunyn-Schmiedeberg's Archives of Pharmacology BPC 157- Reaction / Volume:10mg – 5 vial lab pack (Save 5%) GMP Facility
Pay in 4 interest-free payments of $5.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17